By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BG Medicine today announced it has entered into a secure loan facility for up to $15 million.

The loan facility is with GE Capital's Healthcare Financial Services and Comerica Bank. An initial $10 million was funded to the Waltham, Mass.-based company on Feb. 10. Subject to certain revenue milestones and other conditions being met, BG Medicine may draw an additional $5 million term loan on or before Feb. 10, 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.